{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q6EBC2",
      "entity_text" : "IL-31",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The results demonstrated that higher levels of IL-31 in peripheral blood and elevated IL-31 mRNA in lungs persistently existed during 2 months of airway inflammation, although with a slight decrease at later time-points as compared with those at day 28, indicating that IL-31 modulated the development of airway inflammation in asthma.",
  "reading_complete" : "2020-08-04T12:34:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:33:22Z",
  "trigger" : "modulated",
  "evidence" : [ "IL-31 modulated the development of airway inflammation" ],
  "pmc_id" : "6361213",
  "score" : 0
}